The Project
Medexec was retained by a global mid-sized medical device manufacturer to appoint a new CEO following the planned retirement of their long-standing leader.
The company specialised in minimally invasive surgical technologies with a strong footprint across Europe and Asia-Pacific, and ambitions to scale further into North America and the Middle East.
The incoming CEO would be responsible for:
-
Evolving the global strategy to compete in a highly regulated, innovation-driven market
-
Building commercial capabilities across new markets
-
Driving operational excellence and R&D alignment
-
Leading future M&A activity and potential exit planning
The ideal candidate profile included:
-
A proven CEO or senior P&L leader within the medical devices sector
-
Deep understanding of global regulatory landscapes (EU MDR, FDA, APAC compliance)
-
Experience scaling product portfolios across diverse international markets
-
A track record of building high-performing, cross-functional teams
Our Recommendation
- Conduct a global search strategy across EMEA, North America, and Asia-Pacific.
- Act as a trusted advisor to the board throughout, aligning stakeholders across regions and time zones.
Map and engage senior talent from:
-
Mid-cap and large-cap medical device manufacturers
-
Scale-ups with innovative IP in minimally invasive or diagnostics technologies
Focus on candidates with:
-
Board-level leadership and global P&L accountability
-
Proven success in navigating regulatory complexity across multiple jurisdictions
-
A strong mix of commercial drive, technical credibility, and cultural agility
Results Delivered
- CEO appointed within 10 weeks.
The successful candidate brought:
-
20+ years in the MedTech sector, including as CEO of a €100M turnover surgical devices company
-
Experience leading market entry in North America and APAC
-
Strong relationships with regulatory bodies and clinical communities
The appointment positioned the business for its next growth phase and planned strategic exit.